Poly Medicure Reports QIP Proceeds Utilization for Quarter Ended Sep'26
Poly Medicure Ltd 路 Others (Uncategorized) 路 05 Nov 2026, 8:59 pm
Poly Medicure Reports QIP Proceeds Utilization for Quarter Ended Sep'26 Poly Medicure confirmed zero deviation in utilizing proceeds from its ~Rs 99,999.98 lakh QIP raised in Aug'24. Net proceeds post-issue expenses stood at Rs 98,534.37 lakh, which included a Rs 34.39 lakh surplus from lower issue expenses reallocated to general corporate purposes (GCP). As of 30th Sep'26, the company utilized Rs 58,105.83 lakh: Rs 9,544.62 lakh of Rs 49,973.16 lakh allocated for capex, Rs 25,026.84 lakh fully deployed for inorganic initiatives, and Rs 23,534.37 lakh fully exhausted for GCP. CRISIL Ratings continues as the monitoring agency.
Original exchange filing (PDF)
More announcements from Poly Medicure Ltd
- Enclosed 路 13 Nov 2026
- Enclosed 路 11 Nov 2026
- Please find enclosed herewith Monitoring Agency Report for the quarter ended September 30, 2026. 路 07 Nov 2026
- Please find enclosed herewith intimation of revision of policies and/or code of conduct of the company 路 05 Nov 2026
- Please find enclosed herewith Investor Presentation 路 05 Nov 2026
- Enclosed 路 05 Nov 2026
- Please find enclosed outcome of the board meeting. 路 05 Nov 2026
- Poly Medicure Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
